Heart and hypertension conditions are problems with the heart itself or the vessels that carry its blood: arteries that narrow, a rhythm that misfires, pressure that stays too high, or blood that clots too easily. Red light therapy shines red and near-infrared light, measured in nanometers (nm), onto the skin or, in some trials, directly into the blood. Researchers propose it may relax blood vessels, calm the nerves that speed up the heart, and act on the blood itself. This article outlines what human studies found for each condition and how strong the evidence is.
Human studies cover 13 heart and circulation conditions, taken here in turn: angina, high blood pressure, high cholesterol, coronary artery disease, heart attack, coronary bypass recovery, heart failure, ventricular arrhythmia, atrial fibrillation, peripheral artery disease, blood circulation, Raynaud’s disease, and thrombophlebitis. 8 of them carry enough research for a score, and 6 of those rate Effective, from high blood pressure at 65 out of 100 to angina at 88. Blood circulation returns Mixed Evidence at 46, and heart failure rates Not Effective at 12. The other 5 rest on 1 or 2 studies each, with no score. Much of the evidence on the heart comes from trials that delivered light into a vein or artery, a route no home panel can reproduce.
Every qualifying human study on a condition is rated on the CURE Index (Helio Cure’s proprietary scoring system), which reads and turns the evidence into a score out of 100 and one of three verdicts: Effective, Mixed Evidence, or Not Effective. The Index weighs how strong each study is, how many exist, and how consistently they agree. A condition with fewer than 3 human studies gets no score, so the 5 below that line are reported study by study. Across the scored conditions, wavelengths ran from 400 to 1400 nm, and no single wavelength led: the most used ranged from 632.8 nm for angina to 890 nm for blood circulation. Each section links to the full study list for its scored condition and gives the verdict where the Index has one. The closing answers cover how the light acts on the heart and vessels, where to aim it, how often and for how long, the risks, and which of the studied wavelengths Helio Cure panels run.

Angina
Angina is chest pain caused by too little blood reaching the heart muscle, which feels like pressure, tightness, or squeezing in the center of the chest. It usually appears during physical activity or stress, when the heart works harder, and eases with rest. The common effects are pain spreading to the arm, neck, or jaw, shortness of breath, and tiredness.
Red light therapy for angina earns an Effective verdict, 88 out of 100 on the CURE Index, inside the Strong Confidence band. 5 human studies across 369 participants back the scientific research on angina, in which all 5 studies were rated Effective. Included studies used 632.8 to 1400 nm, and 632.8 nm was used most among effective wavelengths.
High Blood Pressure
High blood pressure, or hypertension, is a sustained rise in the force of blood against artery walls, lifting systolic pressure during each heartbeat, diastolic pressure between beats, or both. Salt, excess weight, and stiffening arteries raise that force, and the strain thickens the heart wall, wears on the kidneys, and increases stroke risk.
For high blood pressure, the CURE Index rates red light therapy 65 out of 100, with an Effective verdict and Moderate Confidence. 8 human studies covering 817 participants make up the evidence on high blood pressure, and their outcomes split 4 Effective and 4 Partially Effective. Wavelengths spanned 620 to 1400 nm, with 635 and 660 nm used most across the set.
High Cholesterol
High cholesterol, or hyperlipidemia, is a raised level of fats in the blood, mainly low-density lipoprotein (LDL) cholesterol, the type that clogs arteries, and triglycerides (the fats the body stores for energy). A diet high in saturated fat, excess weight, inactivity, and inherited genes raise these levels. High cholesterol causes no symptoms of its own, yet the fats slowly build up as plaque inside the arteries, the process behind most heart attacks and strokes.
Those blood fats are what red light therapy was tested on, through a route called intravenous laser irradiation of blood (ILIB). A thin fiber placed in a vein through a needle carries red light at 632.8 nm from a low-power laser straight into the bloodstream, for up to 60 minutes per session. Researchers proposed this route as an add-on for patients who respond poorly to cholesterol drugs or cannot tolerate them. They propose the light acts on blood cells and may improve how the body handles fats.
In 2026, Huang and colleagues at the LOHAS Naturopathic Medical Center of Chang Bing Show Chwan Memorial Hospital in Taiwan published a retrospective pilot study in In Vivo. The team reviewed the records of 60 patients with chronic diseases who received ILIB between July 2022 and February 2024, comparing blood tests from before and after the course. Across the whole group, triglycerides fell from 167.8 to 118.8 milligrams per deciliter (mg/dL), the only marker to change significantly. Total cholesterol and LDL fell in patients whose levels started high, and stayed level in patients whose levels were already normal. Fasting blood sugar and HbA1c, a 3-month blood sugar average, did not change. The authors described a “normalizing” effect rather than a broadly “lowering” effect. However, the study had no comparison group and relied on existing records, so it cannot separate the effect from patients’ medication or lifestyle.
An earlier test of the same route came from Ryu and colleagues at the Korean medicine hospital of Wonkwang University, published in 2004 in the Journal of Internal Korean Medicine. 23 patients with high cholesterol at the university’s Gunpo center received helium-neon laser light delivered into a vein. The team measured 4 blood fats before and after the course, including high-density lipoprotein (HDL), the cholesterol that carries fat away from the arteries. Total cholesterol and LDL fell significantly, while triglycerides and HDL did not change. That pattern is the reverse of the 2026 records, where only triglycerides fell across the whole group. However, the English abstract reports no measured values, session count, or comparison group, so the size of the fall is unknown.
Coronary Artery Disease
Coronary artery disease (CAD) is the narrowing of the coronary arteries, the vessels supplying the heart, by fatty plaque, stiffened artery walls, and blood clots. The common causes are high cholesterol, smoking, and diabetes. The narrowed arteries cause chest pain during activity, shortness of breath, and a heart attack when a clot fully blocks one.
Red light therapy for CAD scores 67 out of 100 on the CURE Index, which rates it Effective, backed by Moderate Confidence. 403 participants across 11 human studies stand behind the trials on coronary artery disease, and the outcomes divide into 7 Effective and 4 Partially Effective. Testing covered 632.8 to 1400 nm, among which 808 nm was the most used wavelength.
Heart Attack
A heart attack happens when a blocked coronary artery cuts off blood to part of the heart muscle. Most cases start when fatty plaque in the artery cracks and a clot forms on it. People feel crushing chest pain that can spread to the arm or jaw, along with breathlessness and sweating. Without blood, heart muscle begins to die within minutes, and the damage spreads over the first hours.
Researchers have tested red light therapy on that loss of heart muscle by 2 routes. The first shines an 808 nm laser on the shinbone for 100 seconds, before doctors reopen the blocked artery and again 1 and 3 days later. The second passes a thin fiber into a vein and lights the blood with a 632.8 nm helium-neon laser in the first hours after the attack. Researchers chose the shinbone because its bone marrow contains stem cells that take part in repairing damaged tissue. They propose the light may prompt those cells to travel to the injured heart, and that light in the blood may limit how far the damage spreads. The evidence is drawn from two studies.
In 2018, Elbaz-Greener and colleagues at Assaf Harofeh Medical Center in Israel published a randomized controlled trial in the Journal of Interventional Cardiology. It enrolled 24 patients having a major heart attack who were about to have the blocked artery reopened with a balloon. 12 received the laser on the shinbone, and 12 had the same device with the power switched off. The light caused no side effects in the trial and did not delay the artery procedure. Troponin-T, a protein that leaks from damaged heart muscle, was significantly lower with the laser, at 2.7 against 5.2 ng/mL. At 9 months, the heart’s pumping strength had improved in both groups, with no significant difference between them. The authors concluded the laser was safe and feasible alongside artery reopening and may benefit the injured heart. However, the trial was small and was designed to test safety, not effect.
In 1990, Kipshidze and colleagues at the Research Institute of Experimental and Clinical Therapy in Tbilisi, then part of the USSR, reported the blood route. The team developed the method and gave it to 295 patients with a first, full-thickness heart attack. Holter monitors, portable recorders that track the heartbeat for 24 hours, were read before and after the light. The authors reported far fewer dangerous fast rhythms of the lower chambers, the rhythms behind sudden death after a heart attack. Heart tracings across the chest and blood levels of creatine phosphokinase, a muscle-damage marker, suggested a smaller area of damage when the light came within the first hours. The authors concluded the method could limit the size of a heart attack and help prevent sudden death.
Coronary Bypass Recovery (CABG)
Coronary bypass recovery is the healing period after coronary artery bypass grafting (CABG), covering breastbone wound closure, fading pain, and the heart's adjustment to restored blood flow. The surgery leaves patients with chest pain, fatigue, and limited walking for several weeks.
The CURE Index rates red light therapy for CABG at 78 out of 100, an Effective verdict with Strong Confidence. 5 human studies with 335 participants evaluate the condition, and the set returns 4 Effective results versus 1 Not Effective. Trials tested 405 to 1400 nm, where 640 nm was used most.
Heart Failure
Heart failure is a long-term condition in which the heart pumps too weakly or fills too poorly for the body’s needs. It usually follows damage from coronary artery disease, a past heart attack, or years of high blood pressure. As the pump weakens, fluid collects in the lungs and legs, bringing breathlessness, swollen ankles, and tiredness.
For heart failure, red light therapy holds a Not Effective verdict at 12 out of 100 by the CURE Index, with Limited Confidence. The research includes 5 human studies and 120 participants, with results of 3 Partially Effective and 2 Not Effective. Wavelengths ranged from 658 to 905 nm, and 808 nm appeared most often.
Ventricular Arrhythmia
Ventricular arrhythmia is an irregular heartbeat that starts in the heart’s lower chambers. It ranges from occasional extra beats to fast rhythms that keep the heart from pumping well. Most cases follow a heart attack or other damage to the heart muscle. People feel a pounding or fluttering heartbeat, dizziness, or faintness. Stress signals from the nerves that speed up the heart make these rhythms more likely.
Researchers have tested red light therapy on those stress signals at a single point in the neck. The method holds a light device against the side of the neck, over the stellate ganglion, the nerve cluster that relays stress signals to the heart. Sessions use light between 600 and 1600 nm, last 7 to 10 minutes, and run 2 to 3 times a week. Researchers chose this spot because numbing the same nerve cluster with injections is already used to calm stubborn fast rhythms. They propose the light may quiet those stress signals without a needle, so less adrenaline reaches the heart, and fast rhythms start less easily. This process is reported in the 2 studies below.
In 2021, Nonoguchi and colleagues at Kyorin University Hospital in Japan reported 2 tests of the method in JACC: Clinical Electrophysiology. First, 20 healthy volunteers had 10-minute sessions twice a week for 4 weeks. Their blood level of adrenaline, the main stress hormone, fell significantly after the light, and a heart-rate measure of stress-nerve activity dropped during sessions. That heart-rate effect had faded by 3 months. Next, the team gave the light to 11 patients with electrical storms, repeated bursts of dangerously fast rhythms. Drugs, sedation, and catheter ablation, a procedure that destroys faulty heart tissue, had not stopped them. The storms settled in 7 patients, though 2 of them relapsed without follow-up sessions, and the light did not control the storms in 4. The authors concluded the light lowered stress-nerve activity and may help some patients as an add-on, though its long-term effect is unknown. However, the patient group had no comparison arm, and the light was added to ongoing hospital care.
A year later, Tanabe and colleagues at Aichi Medical University, also in Japan, reported a single case in BMJ Case Reports. A man in his 60s had cardiac sarcoidosis, an inflammatory disease that scars heart muscle. He also had an implantable cardioverter-defibrillator (ICD), a device that shocks or paces the heart out of dangerous rhythms. After prednisolone, a steroid, was started, the device’s pacing bursts against fast rhythms rose sharply while he was taking amiodarone and sotalol, 2 rhythm drugs. The team added light at 600 to 1600 nm over the stellate ganglion, 7 minutes per session, 2 to 3 times a week for 20 days. Pacing events fell from 371 to 25, and he left the hospital on day 49 without symptoms. The authors concluded the phototherapy was a feasible option for this rhythm in cardiac sarcoidosis. However, the light was given alongside 3 drugs to 1 patient, so the report cannot separate its effect.
Atrial Fibrillation (AFib)
Atrial fibrillation (AFib) is an irregular, often fast heartbeat that starts in the heart’s 2 upper chambers. The common causes are age, high blood pressure, and heart disease. AFib often brings a fluttering heartbeat, breathlessness, and tiredness, and raises the risk of stroke. Drugs that steady the heart’s rhythm control many attacks, but some patients keep having them.
Researchers tested red light therapy on those drug-resistant attacks by adding it to the rhythm drugs rather than replacing them. The method combined a low-power helium-neon laser at 632.8 nm with procainamide, a drug that stops an attack in progress, and amiodarone, a drug that prevents new attacks. They chose this pairing to strengthen drugs that had stopped working well on their own. They propose the light may make the heart respond better to those drugs.
Bobrov and colleagues tested that pairing in a combined program for refractory tachyarrhythmias, fast rhythms that resist drug treatment, publishing their report in 1993. The patients had repeated attacks of atrial tachycardia, atrial fibrillation, or atrial flutter, 3 fast rhythms of the upper chambers. They received the 632.8 nm laser alongside procainamide and amiodarone. The authors reported that the light strengthened procainamide’s ability to stop attacks and amiodarone’s ability to prevent new ones. They concluded the combined program was effective in patients the drugs alone had not controlled. However, this summary carries no patient count, no measured values, and no comparison group.
Peripheral Artery Disease
Peripheral artery disease (PAD) is the narrowing of the arteries carrying blood to the limbs, most often the legs. Smoking, diabetes, and high cholesterol cause most cases by speeding fatty plaque buildup inside those arteries. With less blood, the leg muscles cramp during walking and ease with rest, and wounds on the feet heal slowly.
Red light therapy for PAD stands at 70 out of 100 on the CURE Index, an Effective verdict held at Strong Confidence. Evidence from 150 participants across 3 human studies covers peripheral artery disease, and all 3 studies were rated Effective. Studies used wavelengths from 632.8 to 890 nm, and 650 nm was used most.
Blood Circulation
Blood circulation is the movement of blood through the heart, arteries, veins, and smallest vessels, carrying oxygen and nutrients to every tissue. Circulation slows when narrowed arteries, diabetes, or smoking restrict that flow. Poor circulation shows as cold hands and feet, numbness, and slow-healing cuts.
A CURE Index score of 46 out of 100 gives red light therapy a Mixed Evidence verdict for blood circulation, with Moderate Confidence. Across the trials on blood circulation, 13 human studies with 256 participants produced 6 Effective, 4 Partially Effective, and 3 Not Effective outcomes. Testing ran from 400 to 1064 nm, and 890 nm appeared most often among the effective wavelengths.
Raynaud's Disease
Raynaud’s disease is the sharp narrowing of the small blood vessels in the fingers and toes, turning the skin white, then blue, then red. Most cases have no known cause, while others stem from autoimmune diseases such as scleroderma or lupus. Cold and stress trigger attacks that cause numbness, tingling, and throbbing pain.
Red light therapy for Raynaud’s disease reaches 80 out of 100, an Effective verdict backed by Strong Confidence. Evidence from 258 participants across 5 human studies on Raynaud’s disease lands on 4 Effective and 1 Partially Effective. Testing spanned 625 to 905 nm, with 670 nm leading the effective wavelengths in the set.
Thrombophlebitis
Thrombophlebitis is inflammation of a vein with a blood clot inside it. Most cases involve a superficial vein under the skin of the arm or leg. Common triggers are a drip line left in the arm, cancer drugs given through a vein, varicose veins, and long periods without moving. The vein turns red, warm, and tender, and hardens into a painful cord. Warm compresses and anti-inflammatory painkillers ease the inflammation, yet the hardened vein can take weeks to settle.
That slow-settling, painful vein is what red light therapy was tested on. The method aims a low-power laser directly at the inflamed vein, using red light at 632.8 nm on the legs and 600 to 1600 nm in 10-minute sessions on the arm. Researchers chose the laser for the pain relief it had shown in other inflammatory conditions, such as plantar fasciitis and shoulder tendinitis. They propose that light absorbed in the vein wall and surrounding tissue may calm the inflammation, improve blood flow through the smallest vessels, and ease pain. The evidence lies in the following 2 studies.
In 2015, Hwang and colleagues at Hanyang University Medical Center in the Republic of Korea reported a single case in the Journal of Physical Therapy Science. A 66-year-old woman with breast cancer developed superficial thrombophlebitis in her left arm after chemotherapy. She received 6 sessions of low-level laser therapy (LLLT) at 600 to 1600 nm, 10 minutes each, on the affected arm. Her pain on a 0 to 10 visual analog scale (VAS) fell by 8 points, to 0. On the Patient and Observer Scar Assessment Scale (POSAS), which rates the hardened tissue along the vein (lower is better), the observer score fell by 18 points and her own score by 26. Both gains held to the follow-up check in June 2015. The authors concluded the laser had reduced pain and scar size. However, the authors name 2 limits: a single patient with no control, and a scar scale not yet standardized for this condition.
Dudenko and Zaliubovskiĭ applied a low-intensity helium-neon laser, the LG-75 model, at 632.8 nm to the legs of patients with acute thrombophlebitis, publishing the report in 1989. The authors described marked pain relief, slower blood clotting, stronger immune activity, and an anti-allergic effect. They reported better blood flow through the smallest vessels, more oxygen reaching the tissue, and faster wound healing. They concluded the laser could be used on acute thrombophlebitis and proposed it as a method of choice for trophic ulcers, the slow-healing leg wounds left by poor vein circulation. However, 2 limits apply: there is no comparison group, and no measured values.
Does Red Light Therapy Work for Heart Conditions and Hypertension?
Yes, for 6 of the 8 scored conditions, where the CURE Index rates red light therapy Effective. Angina scores highest at 88 out of 100, then Raynaud’s disease at 80, coronary bypass recovery at 78, peripheral artery disease at 70, coronary artery disease at 67, and high blood pressure at 65, while blood circulation sits at 46 with a Mixed Evidence verdict. Patients in those trials had fewer angina and Raynaud’s attacks, lower blood pressure, less leg pain when walking, and faster-healing bypass wounds. Heart failure is rated Not Effective at 12. The 5 conditions with 1 or 2 studies each returned positive results, but from too few studies to score.
Researchers trace these effects to 3 systems that serve the heart: the blood vessels, the stress nerves, and the blood itself. Many of the strongest results came from light delivered into a vein or artery, which no panel copies, while panel-style trials aimed the light at the arms, hands, and lower legs. Those trials ran from a single session to 6 a week, with changes appearing within days to about 6 weeks. The studies reported few side effects, but anyone taking heart or blood pressure medicine should consult a clinician before beginning sessions.
How Does Red Light Therapy Work for Heart Conditions?
Researchers propose red light therapy acts on the heart mainly through the blood vessels, nerves, and blood that serve it. Light absorbed in the cells’ energy centers frees nitric oxide, a gas the body uses to relax artery walls. Nitric oxide also makes platelets, the cells that form clots, less likely to clump together. Wider arteries and less sticky blood may ease blood pressure, improve circulation, and lower clotting. Light over a nerve cluster in the neck acts on the stress signals that speed up the heart. Light delivered into a vein acts on blood cells and blood fats directly.

How to Use Red Light Therapy for Heart and Hypertension?
Aim the light at bare skin over the forearms, hands, or lower legs, where many of the circulation and blood pressure trials placed it, holding the panel within about 8 inches (20 centimeters). However, a panel cannot copy the routes behind most heart results in this article: light fed into a vein or artery, or from a hospital device over a nerve in the neck. Keep taking prescribed heart and blood pressure medicines, and consult a clinician before beginning sessions, especially with a pacemaker, defibrillator, or recent heart attack.

How Frequently Should You Use Red Light Therapy for Heart Conditions?
Use red light therapy 2 to 5 times a week across a course of 3 to 6 weeks, which sits inside the range the blood pressure, artery, and Raynaud's trials ran. Those trials gave anywhere from a single session to 6 a week, over a single day to about 4 months. Stop and see a doctor if chest pain, palpitations, or dizziness appear during a course.
How Long Does Red Light Therapy Take to Act on Heart Conditions?
In the trials on this page it took a few days to about 6 weeks for red light therapy to start acting on the heart, depending on the condition. Markers of heart damage after bypass surgery or a heart attack fell within the first week, while blood pressure, leg circulation, and Raynaud’s attacks improved over 4 to 6 weeks. In angina, relief appeared about a month after a 10-day course ended and still held in 62.5% of patients at 6 months. Some gains faded once sessions stopped, as fast heart rhythms returned in some patients without follow-up sessions. Evaluate the course at the end, and never change heart medication without a doctor’s advice.
Are There Any Risks of Using Red Light Therapy for Heart and Hypertension?
The studies on this page reported few side effects, and no serious adverse effects from the light. A panel gives off little heat, and it is wise to wear protective eyewear. Some heart and blood pressure medicines, such as amiodarone and hydrochlorothiazide, make skin more sensitive to light. Consult a clinician before beginning sessions.
Do Helio Cure Panels Use the Wavelengths Studied for Heart Conditions and Hypertension?
Yes. Helio Cure panels run 630, 660, 810, 830, 850, and 1064 nm. The coronary bypass recovery studies used 640 nm most, the angina and coronary artery disease studies used 632.8 and 808 nm most, a few nanometres from the panels’ 630 and 810 nm, and the Raynaud’s and peripheral artery disease studies used 670 and 650 nm most, each 10 nm from the panels’ 660 nm. The blood circulation studies used 890 nm most, which the panels do not run, though their trials also used 830, 850, and 1064 nm on the arm and foot. The heart attack trial aimed 808 nm at the shinbone, 2 nm from the panels’ 810 nm.
References
- https://pubmed.ncbi.nlm.nih.gov/8059388/
- https://pmc.ncbi.nlm.nih.gov/articles/pmid/34336126/
- https://pubmed.ncbi.nlm.nih.gov/2221480/
- https://linkinghub.elsevier.com/retrieve/pii/S0024-3205(16)30108-4
- https://doi.org/10.1111/joic.12539
- https://pmc.ncbi.nlm.nih.gov/articles/pmid/41482358/
- https://pmc.ncbi.nlm.nih.gov/articles/pmid/26834384/
- https://pubmed.ncbi.nlm.nih.gov/2811172/
- https://journals.sagepub.com/doi/10.1177/17085381211051489
- https://doi.org/10.1046/j.1524-4725.1999.08268.x
- https://pubmed.ncbi.nlm.nih.gov/2463392/
- https://pmc.ncbi.nlm.nih.gov/articles/pmid/35863858/
- https://linkinghub.elsevier.com/retrieve/pii/S2405-500X(21)00440-0
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9808891



